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Abstract: A homology model of the most frequently
used, but thermally somewhat labile, Baeyer–Villiger
monooxygenase, cyclohexanone monooxygenase
(CHMO) has been derived on the basis of the recent-
ly published crystal structure of the thermally stable
phenylacetone monooxygenase (PAMO). This has
led to the identification of a structural element crucial
for substrate acceptance and stereoselectivity, namely
an arginine-interacting loop near the active site. A
bulge in this loop occurring in PAMO (but not in
CHMO) has been eliminated by mutation, enhancing
the range of substrate acceptance and enantioselectiv-
ity of Baeyer–Villiger reactions while maintaining
high thermal stability.
Keywords: asymmetric catalysis; enzymes; molecular
modeling; oxidation; protein engineering; protein
structures
Introduction
The Baeyer–Villiger (BV) reaction of ketones with for-
mation of the corresponding esters or lactones is an im-
portant transformation in synthetic organic chemistry.[1]
It can be catalyzed by acids, bases, metal complexes or
flavin-dependent enzymes. The latter are generally
called Baeyer–Villiger monooxygenases (BVMOs),[2]
an example of which are the cyclohexanone monooxy-
genases (CHMOs).[2,3] It has been shown that in this en-
zymatic process dioxygen (air) reacts with the reduced
enzyme-bound flavin (FAD) to form an intermediate
peroxide-anion which, in the deprotonated form, ini-
tiates the BV reaction by nucleophilic addition to the
carbonyl function.[2,3] This process leads to the so-called
Criegee intermediate which then rearranges to the ester
(or lactone). Ultimately O2 delivers one oxygen atom to
the substrate, the other being reduced to water (Scheme
1). The oxidized flavin then needs to be recycled by re-
duction, the coenzyme NADPH taking over this func-
tion. Therefore, when employing the isolated CHMOs,
NADPHitself has to be recycled. For this reasonorganic
chemists have found it more convenient to use whole
cells.[2–4] Employing CHMO-containing strains from
various organisms, this procedure has been applied suc-
cessfully in the kinetic resolution of a variety of different
chiral ketones and in the desymmetrization of various
prochiral substrates (often>90%ee).[3,4] Of course, sub-
strate acceptance and enantioselectivity are by nature
limited. For this reason we recently extended the syn-
thetic value of this biocatalytic process by applying the
methods of directed evolution in order to control the de-
gree and direction of enantioselectivity.[5] In that study
whole-cell preparations of E. coli expressing the re-
combinant CHMO[6] from Acinetobacter sp. NCIMB
9871 were used.[5] However, due to the fact that at that
time not a single BVMO had been structurally charac-
terized by X-ray crystallography, it was not possible to
relate the results to a molecular basis.
Most recently, Malito, Alfieri, Fraaije andMattevi re-
ported the first crystal structure of a BVMO.[7] The so-
called phenylacetone monooxygenase (PAMO) from
the moderately thermophilic bacterium Thermobifida
fusca, discovered previously by genome mining,[8] was
shown to exhibit a two-domain architecture resembling
structural characteristics of disulfide oxidoreductases.
The crystal structure reveals a cleft at the domain inter-
face, at which the active site is located. Arginine at posi-
tion 337 was identified above the bound flavin ring in a
position ideally suited to stabilize the negatively charg-
ed flavin peroxide.[7] Two further points deserve men-
tion: Firstly, this BVMO is the thermally most robust
of its kind known to date, making it an attractive candi-
date for potential application in organic chemistry. Sec-
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ondly, of various ketone substrates tested in the BV re-
action, phenylacetone was shown to be oxidized most
rapidly.[8] PAMO appears to prefer substrates bearing
phenyl groups, although it is currently not possible to de-
fine the pocket in which the aromatic moiety binds. In
contrast, ketones such as cyclohexanone are not accept-
ed or react extremely slowly.[8] Thus, PAMO has the at-
tractive feature of being unusually stable, but its range of
substrate acceptance is rather limited and enantioselec-
tivity is low.[8]
InMlheim we became interested in the crystal struc-
ture of PAMObecause it allowed us to construct a struc-
tural model of the wild-type (WT) CHMOand the high-
ly enantioselective mutants that we had created earlier
by directed evolution.[5] Moreover, another point of in-
terest emerged, which is the subject of the present study.
Upon comparing the CHMO homology model with the
crystal structure of PAMO, a remarkable structural dif-
ference became apparent, namely the presence of a
bulge in the loop near the active site of PAMO which
is absent in CHMO (see below). One can imagine that
the presence of this bulge places limits on the range of
substrate acceptanceofPAMO.Therefore, full or partial
elimination of the bulge could turn the PAMO into an
enzyme variant displaying an enlarged substrate accept-
ance while maintaining its thermal stability. This in-
spired us to perform “rational” engineering of PAMO
with theaimofobtaininga “phenylcyclohexanonemono-
oxygenase” (PCHMO). Indeed, 2-phenylcyclohexa-
none is a substrate that is hardly accepted by the WT
PAMO.
Results and Discussion
Homology Model of CHMO
In order to generate a structural model of CHMObased
on the crystal structure of PAMO (pdb-code 1W4X), we
applied the CBS-CPHmodels-2.0 3D-homology model-
ing server.[9] The sequence identity of the CHMO (523
amino acids) and PAMO (524 amino acids) is 40.3%,
and the calculated BLAST-alignment score is 526. Fig-
ure 1 shows a portion of the CHMO/PAMO alignment
focusing on the differences in the arginine-interacting
loops of the two enzymes.
All conserved motifs typical of flavin and nicotin-
amide cofactor binding sites and other known sequence
motifs for monooxygenases[10] are correctly aligned,
which speaks for the reliability of the predicted 3Dmod-
el. Figure 2 (top) shows the overall fold of PAMO and
the CHMO homology model. As already mentioned in
the introduction, the most prominent structural differ-
ence between PAMO and CHMO is the presence of
an additional bulge in one of the loops of PAMO. The
bulge is defined by Ser-441, Ala-442 and Leu-443 (com-
pare Figure 1). This loop occurs in the FAD-binding do-
main and is spatially located next to the catalytic argi-
nine (Arg-337) (Figure 2, bottom).As delineated below,
Arg-337 is instrumental in stabilizing the negatively
charged flavin peroxide intermediate. Our previous
work concerning the directed evolution of enantioselec-
tive BV monooxygenases showed that position 432 of
CHMO is one of the important hot spots, and we now
Scheme 1. Schematic representation of BVMO-catalyzed Baeyer–Villiger reactions of ketones.
Figure 1. Differences in the arginine-interacting loop between PAMO and CHMO. Excerpt of the sequence alignment be-
tween PAMO and CHMO. Identical residues are shaded black and homologous residues are in gray. The blue box surrounds
the arginine-interacting loop. The amino acids that were mutated in this study are colored red.
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know that it occurs in the corresponding (shorter) argi-
nine-interacting loop. Mutations at this position have a
dramatic influence on the direction and magnitude of
enantioselectivity of BV reactions[5] and sulfoxidation
of prochiral thioethers.[11] In our homology model of
CHMO Phe-432 occurs at the position corresponding
to Leu-443 at the start of the bulge in PAMO (for align-
ment see blue box in Figure 1).
Mutational Studies at the Bulge of PAMO
Our immediate goal was to generate three PAMO var-
iants bymanipulating the bulge in the arginine-interact-
ing loop in the following way:
* P1: deletion of Ala-442,
* P2: deletion of Ala-442 and Leu-443, and
* P3: deletion of Ser-441 and Ala-442.
The enzyme variants were generated by Quick-Change
PCR from the pPAMO-vector described elsewhere and
expressed inE. coliTOP10-cells (seeExperimental Sec-
tion).[8]
Catalytic Profile of the PAMO Variants
We initiated the study of substrate acceptance by sub-
jecting phenylacetone (1) and 2-phenylcyclohexanone
(3) to theBV reaction using the purified PAMOvariants
Figure 2. Comparison of the crystal structure 1W4X of PAMO (left) and the homology model of CHMO (right) with 40.3%
sequence identity. The upper part shows the overall fold and the lower part is a zoom into the active site showing the FAD
cofactor as solid sticks and the catalytic arginine in ball-and-stick model. The yellow color highlights the presence of two addi-
tional amino acids in the arginine-stabilizing loop of PAMO compared with CHMO drawn as a backbone representation.
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in the presence of defined amounts ofNADPH.Enzyme
activity was determined by UV/Vis spectroscopy by
monitoring the decrease in NADPH concentration,
which is conveniently possible by measuring the de-
crease in characteristic absorbance at 340 nm. All ex-
periments were performed at 25 8C using air-saturated
Tris-HCl buffers according to a modified literature pro-
cedure.[8]
The steady-state kinetic parameters (Michaelis–
Menten) are summarized in Table 1. It can be seen
that the catalytic profile is clearly changed by deleting
the bulge from the arginine-interacting loop. A cyclo-
hexanone derivative such as 2-phenylcyclohexanone
(3), which is hardly turned over by the WT PAMO
with a conversion barely reaching 10% inwhole-cell cat-
alysis within 24 hours (see below), shows almost full con-
version with, for example, mutant P3 as catalyst.Mutant
P3 has a KM value of 0.07 mM for 2-phenylcyclohexa-
none (3), comparable to the KM of 0.059 mM observed
for the WT PAMO with respect to phenylacetone
(1).[8] The conversion of 2-phenylcyclohexanone (3) by
mutant P2, the second PAMO variant with the size of
the arginine-positioning loop being reduced to the size
of the corresponding loop in CHMO, is comparable to
mutant P3. Its KM towards this substrate is 0.5 mM.
This indicates that steric constraints applied by the argi-
nine-interacting loop play a major role in the substrate
binding by the enzyme. The significant differences in
KM values between mutants P2 and P3, on the other
hand, suggest further interactions that cannot be readily
explained at this time.
While increasing the affinity for cyclohexanone deriv-
atives by deleting the bulge, the catalytic efficiency in
the oxidation of the parent substrate phenylacetone
(1) is actually decreased. Although we could get high
conversions in whole-cell catalysis, the KM values for
all three generated PAMO variants are significantly in-
creased over that of the WT enzyme. Importantly, the
thermostability of the new PAMO variants is compara-
ble to that of the wild-type and was determined at
50 8C. For variant P1 we found a half-life time of
29 h2 h with a free energy for the denaturation of
105.3 kJ/mol0.5 kJ/mol, for variants P2 and P3 half-
life times of 16 h3 h (103.7 kJ/mol0.5 kJ/mol) and
17 h2 h (103.9 kJ/mol0.5 kJ/mol), respectively.
These half-life times are comparable to those measured
for the wild-type enzyme.[8]
We then turned to the use of whole cells and expanded
the list of substrates to include ketones 5–8. The results
show that, under the conditions used, only those ketones
undergo BV reactions that have a phenyl group near the
carbonyl function, namely 1, 3 and 7. In contrast, cyclo-
hexanone (5), 4-phenylcyclohexanone (6) and proges-
terone (8) do not react to any appreciable extent.
Compounds 3 and 7 are chiral, which offers the oppor-
tunity to study kinetic resolution. Although the WT
PAMO requires very long reaction times for reasonable
conversion, it was included in the study. Table 2 shows
the conversions and enantioselectivities obtained in
whole-cell catalysis of ketones 3 and 7. WT PAMO oxi-
Table 1. Steady-state kinetic parameters of WT PAMO and variants.
Substrate PAMO variant KM [mM] kcat [s
1] kcat/KM [M
1 s1]
1 WT[a] 0.059 1.9 32000
1 P1 31 0.250.02 82
1 P2 42 0.400.04 99
1 P3 2.50.4 0.220.01 89
3 WT n.d. n.d. n.d.
3 P1[b] 2.30.5 0.310.03 134
3 P2[b] 0.50.1 0.50.2 1054
3 P3[b] 0.070.01 0.250.02 3395
[a] Literature value measured without addition of acetonitrile.[8]
[b] A racemic mixture was used.
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dizes ketone 3 with low conversions and essentially no
stereoselectivity, whereas we observed increasing con-
versions in the case of the mutants in the order P1
<P2<P3.Themost active PAMOvariant P3 also shows
excellent stereoselectivity in the kinetic resolution of
ketone 3. An E value of 100 at 50% conversion was ob-
tained after 2 h of reaction in favor of (R)-4. Significant-
ly, the WT CHMO also shows (R) selectivity in this ki-
netic resolution with an E-value of>100.[12] However,
as already pointed out its thermal stability is fairly low.
Thus, mutant P3 is characterized by the thermal stability
of WT PAMO and the high enantioselectivity of WT
CHMO.
Conversion of substrate 7 is in general less efficient
than that of substrate 3. It is significantly converted
only bymutant P3. In this reaction only one enantiomer-
ic form of lactone 9 could be detected by chiral GC at a
conversion of 40% (E>200) in favor of the (R)-product,
which again is similar to the oxidation by the WT
CHMO.
Since in our previous work concerning the directed
evolution of CHMOs we had discovered that certain
mutants are not only excellent catalysts for asymmetric
BV reactions,[5] but also for enantioselective oxidations
of prochiral thioethers,[11] we decided to test the PAMO
variants in the sulfoxidation of thioether 10.[4f–m] PAMO
variant P3 turned out to be quite enantioselective, lead-
ing to an ee value of 90% in favor of the (R)-11. For com-
parison, WT PAMO and CHMO give an ee value of
79.5% and 14%, respectively.
Molecular Modeling of the Criegee Intermediate
We compared the structure of the active sites and ana-
lyzed the differences by modeling the Criegee inter-
mediate arising from the reaction of 2-phenylcyclohexa-
none (3) into the PAMO crystal structure and the creat-
ed CHMOhomologymodel using the united atom force
field MAB as implemented in MOLOC with implicit
solvation.[13] The structures were subsequently mini-
mized and relaxed by molecular dynamics to analyze
the geometry of the active site with bound substrate ac-
cording to aprocedure described previously.[13c] Thiswas
required because we started from an experimental crys-
tal structure without bound ligand. This exploratory
modeling shows that a difference in the arginine-inter-
acting loop between PAMO and CHMO, namely the
bulge defined by Ser-441, Ala-442 and Leu-443 in
PAMO, sterically constrains Arg-337 and thus prevents
conversion of cyclic ketones.
We then modeled the substrate 3 into the PAMO var-
iant P3 in which Ser-441 and Ala-442 are deleted. Fig-
ure 3 shows that a shortening of this active site loop by
two amino acids leads to a PAMO variant which is
able to bind 2-phenylcyclohexanone (3) in the form of
a Criegee intermediate, the latter being stabilized by
H-bonding to Arg-337 (Figure 3). In sharp contrast,
theWTPAMOdoes not provide enough space in the ac-
tive site to position substrate 3 in the form of a Criegee
intermediate due to the presence of the bulge. Thus, we
propose that the nature of the arginine-interacting loop
(Figure 2) is responsible for the different substrate rec-
ognitionwhen going from linear ketones like phenylace-
tone (1) to cyclic ketones like 2-phenylcyclohexanone
Table 2. Kinetic resolution of ketones 3 and 7 using whole cells.
Ketone Enzyme variant E[a] % conversion after 24 h Preferred enantiomer
3 WT-PAMO 1.2 10 S
3 P1 35 51 R
3 P2 23 72 R
3 P3 100 91 R
7 WT-PAMO – 0 –
7 P1 – 0 –
7 P2 – 0 –
7 P3 >200 40 R
[a] E-values were calculated on the basis of 40–50% conversion (except for the WT).
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(3). The reason for the necessity of phenyl groups near
the carbonyl function still needs to be clarified.
Conclusions
Since the early work of Taschner[4a] describing the appli-
cation of Baeyer–Villiger monooxygenases as catalysts
in organic chemistry, a number of other synthetic organ-
ic chemists have exploited these enzymes in asymmetric
transformations, usually employing a CHMO in the
form of whole cells.[2–4] In spite of the pioneering mech-
anisticwork of a number of biochemists,[2] detailed inter-
pretations of asymmetric BV reactions have not been
possible due to the long-standing problem of obtaining
suitable crystals of these relatively unstable enzymes,
making crystallographic characterization impossible.
For this reason all published models of the stereochem-
ical outcome of enzyme-catalyzed BV reactions consti-
tute useful mnemonic devices,[3,4,14] but they really do
not include structural aspects on a molecular basis.
The recently published crystal structure of a thermosta-
ble Baeyer–Villiger monooxygenase PAMO[7] has
changed the situation. PAMO has a relatively narrow
range of substrate acceptance, but it is thermally ro-
bust.[8] In the present studywe have utilized the structur-
al information in order to construct a homology model
of the widely used CHMO. As a result we have been
able to apply molecular modeling, which has emerged
in the identification of a structural element essential in
enzyme-catalyzed BV reactions: the arginine-interact-
ing loop, as shown in Figures 1 and 3. The presence of
this loop seems to be conserved throughout BVMOs.
We have shown that manipulation of this structural ele-
ment strongly influences substrate acceptance andenan-
tioselectivity.
The comparison of the crystal structure of the WT
PAMO with the CHMO homology model allowed us
to rationally redesign the PAMO with the goal of ex-
panding the range of its substrate acceptance while
maintaining thermal stability. The PAMO was success-
fully turned into a phenylcyclohexanone monooxyge-
nase (PCHMO). This was accomplished by deletingma-
jor parts of a bulge occurring in the arginine-interacting
loop near the active site. The observation that fast turn-
over requires the presence of a phenyl group near the
carbonyl function of the ketone substrate illuminates
the scope and limitation of the present PAMO variants.
This structural feature is currently difficult to explain,
and we refrain from unfounded speculations. Neverthe-
less, on the practical side the developments described in
this study can be considered to be steps towards the ul-
timate goal of creating thermostable BV monooxyge-
nases showing broad substrate acceptance and high de-
grees of enantioselectivity. One logical approach would
be to perform saturation or cassette mutagenesis[15] in
the arginine-interacting loop. Finally, the structural
andmechanistic information emerging from the present
study is helping us in the interpretation of the results of
our previous investigation concerning the directed evo-
lution of enantioselectiveCHMOs.[5,11] One of themuta-
tions occurring at an important “hot spot” responsible
for enhanced stereoselectivity was reported to be
F432S, which we can now identify as being in the loop
near the active site. Ser-432 probably forms a hydrogen
bond with the catalytically active arginine. More de-




Phenylacetone (1), 2-phenylcyclohexanone (3), cyclohexa-
none (5), 4-phenylcyclohexanone (6), 2-benzylcyclohexanone
(7) and progesterone (8) were obtained from Aldrich and Flu-
ka. p-Methylbenzylmethyl sulfidewas synthesized using a pro-
cedure described in the literature. Racemic lactones for GC
analysis were synthesized bymCPBAoxidation of the ketones.
NADPH was obtained from Jlich Fine Chemicals. DNA se-
quencing was done at Medigenomix (Martinsried, Germany).
Mutation and Expression of Recombinant PAMO
pPAMOwas purified from E. coli TOP10 cells using the QIA-
prepr Spin Miniprep Kit and subjected to Quick-Change PCR
following the Stratagene Quick-Change-Kit protocol (Strata-
gene) with HotStart KOD-Polymerase (Novagen) using the
following primers:
Figure 3.Model of the PAMO variant P3 with deleted Ser-
441 and Ala-442 containing the Criegee intermediate arising
from 2-phenylcyclohexanone (3) in a reactive geometry with
two H-bonds originating from the catalytic Arg-337.
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P1-fw: 5’-aggcccgggcagcccgtctctcagcaacatgctggtct-3’, P1-
rev: complementary to P1-fw,
P2-fw: 5’-aggcccgggcagcccgtctagcaacatgctggtctcta-3’, P2-
rev: complementary to P2-fw,
P3-fw: 5’-gcaggcccgggcagcccgctcagcaacatgctggtc-3’, P3-rev:
complementary to P3-fw.
The resulting plasmids were transformed into E. coli
TOP10. Integrity of the coding region was verified byDNA se-
quencing. For expression the cells were cultivated in either LB-
Medium (forwhole-cell catalysis) or TB-Medium (for purifica-
tion of the PAMO variants) supplemented with 0.1% l-arabi-
nose and 100 mg/mL carbenicilline at a temperature of 37 8C.
Purification of Recombinant PAMO Variants
Purification of the PAMOvariants was performed as described
elsewhere for WT PAMO with minor modifications.[8]
Steady-State Kinetics
Protein concentrations were measured photometrically by
monitoring the absorption of the FAD-cofactor at 441 nm
(e441¼12.4 mM1 cm1). For steady-state kinetics purified
PAMO mutants at a concentration of 1 mM were dissolved in
50 mM Tris-HCl (pH 8.0) in the presence of 100 mMNADPH.
Substrates were dissolved in acetonitrile and added to the pre-
mixed enzyme solution resulting in an acetonitrile concentra-
tion of 2.5% (v/v). NADPH consumption was continuously
measured at 340 nm (e340¼6.22 mM1 cm1). The kinetics
were measured at 25 8C. The obtained data were fitted to the
Michaelis–Menten equation by non-linear regression analysis
implemented in the programOrigin 7.0 (Microcal, Northamp-
ton,MA). Formeasuring the thermostability of thePAMOvar-
iants, solutions of the purified enzymes were incubated at
50 8C. Activity was determined as described above in the pres-
ence of 20 mM phenylacetone (substrate saturation condi-
tions). The data were fitted to a single exponential decay curve
using Origin 7.0 and the half-life time was calculated. The free
energy of denaturation was calculated from the deactivation
rate kd using the formula:
Whole-Cell Catalysis
For whole cell catalysis TOP10-expression cultures in LB-Me-
diumwere grown to anOD600 of 2.5–3.0 and subsequently sup-
plemented with 5 g/L of glycerol. The PAMO variants were
heat-activated at 45 8C (15 min for 20 mL of culture). After-
wards the biocatalytic reactions were started as described be-
low.
Baeyer–Villiger Oxidation of 2-Phenylcyclohexanone
(3) and 2-Benzylcyclohexanone (7)
20 mL of heat-treated TOP10-expression culture were mixed
with 280 mL of a 0.1 M solution of 2-phenylcyclohexanone (3)
or 2-benzylcyclohexanone (7), respectively, in acetonitrile. In
the case of 2-benzylcyclohexanone (7) 1 mL of a solution of
2-hydroxypropyl-b-cyclodextrin (Wacker CAVASOLW7 HP
Pharma, 134.3 mg/mL in water) was added for solubilization.
The culture was further grown at 37 8C in 100-mL Erlenmeyer
flasks. Samples were taken at various time intervals and ex-
tractedwith 2 equivalents of ethyl acetate and subsequently an-
alyzed by chiralGC (column and condition: 30 mBGB177 and
BGB 15 column, respectively, 0.25 mm i.d., 0.25 mm film;
G/468; 0.5 bar hydrogen pressure, 76 min isotherm 130 8C,
25 min, isotherm 200 8C, 15 min). The assignment of absolute
configuration of the resulting lactones is based on literature
data.[12] In the case of kinetic resolution, the formula of Sih[16]
was used to obtain the E values.
Sulfoxidation of p-Methylbenzyl Methyl Sulfide (10)
20 mL of heat-treated TOP10-expression culture were mixed
with 15 mL of neat p-methylbenzyl methyl sulfide (10) and
3 mL of a solution of 2-hydroxypropyl-b-cyclodextrin (Wacker
CAVASOLW7 HP Pharma, 134.3 mg/mL in water) were add-
ed. The culture was further grown at 30 8C and extracted with 2
equivalents of dichloromethane and analyzed by chiral HPLC
as previously described.[11]
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